Phase 1 Study of Cabozantinib in Combination with Topotecan-Cyclophosphamide for Patients with Relapsed Ewing Sarcoma or Osteosarcoma
NOT ENROLLING
Trial ID:
NCT04661852 Protocol # :
20-535
Phase
I
Disease Sites
Bones and Joints
Principal Investigator
Dubois, Steven
Site Research Nurses
Carrozza, Susan, J.
Cavanaugh, Kerri, Lynn
Limor, Sora
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #20-535
20-535